Management options for minimal hepatic encephalopathy (Q37353093)

19 August 2017

Management options for minimal hepatic encephalopathy (English)

1 reference

19 August 2017

1

Jasmohan S Bajaj

1 reference

19 August 2017

1 December 2008

1 reference

Expert Review of Gastroenterology & Hepatology

19 August 2017

1 reference

19 August 2017

2

1 reference

19 August 2017

6

1 reference

19 August 2017

785-790

1 reference

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

19 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

21 January 2018

Hepatic Encephalopathy.

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

High prevalence of sleep disturbance in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Influence of recent advances in medical management on clinical outcomes of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Minimal hepatic encephalopathy impairs fitness to drive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Neuropsychological characterization of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Neuropsychological abnormalities in cirrhosis include learning impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Attention, memory, and cognitive function in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

[Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Inhibitory control test for the diagnosis of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Patients with minimal hepatic encephalopathy have poor insight into their driving skills

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Therapeutic studies in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Acetyl-L-carnitine treatment in minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

A randomized controlled trial of acarbose in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2.6.785

21 January 2018

Identifiers

DOI

10.1586/17474124.2.6.785

1 reference

19 August 2017

1 reference

PubMed ID

19090738